Akari Therapeutics Capital Expenditures (CapEx) Growth & History (AKTX)

Akari Therapeutics's capital expenditures (capex) was $0 for fiscal 2019.

View full Akari Therapeutics company overview

Akari Therapeutics annual capital expenditures (capex) history

Akari Therapeutics annual capital expenditures (capex)

Fiscal yearPeriod endedCapital expenditures (CapEx)ChangeGrowth
20192019-12-31$0$0
20182018-12-31$0−$36,885
20172017-12-31$36,885−$17,865−32.63%
20162016-12-31$54,750$44,190+418.47%
20152015-12-31$10,560$10,560
20142014-12-31$0$0
20132013-12-31$0$0
20122012-12-31$0$0
20112011-12-31$0$0
20102010-12-31$0

Akari Therapeutics capital expenditures (capex) trends

Over the last five fiscal years, Akari Therapeutics's capital expenditures (capex) increased from $0 to $0, a change of $0. The latest reported quarter, Q2 2016, shows $5,897.

About the metric

What capital expenditures (CapEx) mean

Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.

Calculation and source

SEC-reported capital expenditures

TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Akari Therapeutics source filings ↗

Community posts

It’s quiet here.

No posts about AKTX yet. Start the conversation.

Write the first post